These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37228302)

  • 21. Survival status and its predictors among multi-drug resistance tuberculosis treated patients in Ethiopia: Multicenter observational study.
    Bade AB; Mega TA
    PLoS One; 2020; 15(11):e0241684. PubMed ID: 33166299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia.
    Adane K; Ameni G; Bekele S; Abebe M; Aseffa A
    BMC Public Health; 2015 Jun; 15():572. PubMed ID: 26092570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia.
    Mekonnen F; Tessema B; Moges F; Gelaw A; Eshetie S; Kumera G
    BMC Infect Dis; 2015 Oct; 15():461. PubMed ID: 26503269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for mortality among multi-drug resistant tuberculosis patients in treatment follow-up centers, eastern Ethiopia: a retrospective follow-up study.
    Bofe KU
    Pan Afr Med J; 2022; 43():78. PubMed ID: 36591001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial.
    Lee M; Mok J; Kim DK; Shim TS; Koh WJ; Jeon D; Lee T; Lee SH; Kim JS; Park JS; Lee JY; Kim SY; Lee JH; Jo KW; Jhun BW; Kang YA; Ahn JH; Kim CK; Shin S; Song T; Shin SJ; Kim YR; Ahn H; Hahn S; Won HJ; Jang JY; Cho SN; Yim JJ
    Trials; 2019 Jan; 20(1):57. PubMed ID: 30651149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China.
    Alene KA; Yi H; Viney K; McBryde ES; Yang K; Bai L; Gray DJ; Clements ACA; Xu Z
    BMC Infect Dis; 2017 Aug; 17(1):573. PubMed ID: 28814276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knowledge and practice of health workers about control and prevention of multidrug-resistant tuberculosis in referral hospitals, Ethiopia: a cross-sectional study.
    Alene KA; Adane AA; Yifiru S; Bitew BD; Adane A; Koye DN
    BMJ Open; 2019 Feb; 9(2):e022948. PubMed ID: 30782870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of multidrug-resistant tuberculosis (MDR-TB) in Ethiopia: a systematic review and meta-analysis of the prevalence, determinants and treatment outcome.
    Girum T; Muktar E; Lentiro K; Wondiye H; Shewangizaw M
    Trop Dis Travel Med Vaccines; 2018; 4():5. PubMed ID: 29942536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spatial patterns of multidrug resistant tuberculosis and relationships to socio-economic, demographic and household factors in northwest Ethiopia.
    Alene KA; Viney K; McBryde ES; Clements AC
    PLoS One; 2017; 12(2):e0171800. PubMed ID: 28182726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. More than half of presumptive multidrug-resistant cases referred to a tuberculosis referral laboratory in the Tigray region of Ethiopia are multidrug resistant.
    Tesfay K; Tesfay S; Nigus E; Gebreyesus A; Gebreegziabiher D; Adane K
    Int J Mycobacteriol; 2016 Sep; 5(3):324-327. PubMed ID: 27847018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment outcomes of patients with MDR-TB and its determinants at referral hospitals in Ethiopia.
    Wakjira MK; Sandy PT; Mavhandu-Mudzusi AH
    PLoS One; 2022; 17(2):e0262318. PubMed ID: 35176035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Machine learning and radiomics for the prediction of multidrug resistance in cavitary pulmonary tuberculosis: a multicentre study.
    Li Y; Wang B; Wen L; Li H; He F; Wu J; Gao S; Hou D
    Eur Radiol; 2023 Jan; 33(1):391-400. PubMed ID: 35852573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.
    Parmar MM; Sachdeva KS; Dewan PK; Rade K; Nair SA; Pant R; Khaparde SD
    PLoS One; 2018; 13(4):e0193903. PubMed ID: 29641576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival analysis of time to cure on multi-drug resistance tuberculosis patients in Amhara region, Ethiopia.
    Limenih YA; Workie DL
    BMC Public Health; 2019 Feb; 19(1):165. PubMed ID: 30732601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of pulmonary multidrug-resistant tuberculosis patients in Tigray Region, Ethiopia: A cross-sectional study.
    Welekidan LN; Skjerve E; Dejene TA; Gebremichael MW; Brynildsrud O; Agdestein A; Tessema GT; Tønjum T; Yimer SA
    PLoS One; 2020; 15(8):e0236362. PubMed ID: 32797053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia.
    Demile B; Zenebu A; Shewaye H; Xia S; Guadie A
    BMC Infect Dis; 2018 May; 18(1):249. PubMed ID: 29855354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.
    Hamusse SD; Teshome D; Hussen MS; Demissie M; Lindtjørn B
    BMC Public Health; 2016 Jul; 16():593. PubMed ID: 27430266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and predictors of tuberculosis occurrence among adults on antiretroviral therapy at Debre Markos referral hospital, Northwest Ethiopia: retrospective follow-up study.
    Aemro A; Jember A; Anlay DZ
    BMC Infect Dis; 2020 Mar; 20(1):245. PubMed ID: 32216747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: a 13-year experience.
    Liu CH; Li L; Chen Z; Wang Q; Hu YL; Zhu B; Woo PC
    PLoS One; 2011 Apr; 6(4):e19399. PubMed ID: 21559362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of Serial Multidrug-Resistant Tuberculosis Strains Causing Treatment Failure and Within-Host Evolution by Whole-Genome Sequencing.
    Chen X; He G; Lin S; Wang S; Sun F; Chen J; Zhang W
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33361124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.